148 related articles for article (PubMed ID: 16480262)
1. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
Hajjar E; Korkmaz B; Gauthier F; Brandsdal BO; Witko-Sarsat V; Reuter N
J Med Chem; 2006 Feb; 49(4):1248-60. PubMed ID: 16480262
[TBL] [Abstract][Full Text] [Related]
2. Design and use of highly specific substrates of neutrophil elastase and proteinase 3.
Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667
[TBL] [Abstract][Full Text] [Related]
3. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies.
Fujinaga M; Chernaia MM; Halenbeck R; Koths K; James MN
J Mol Biol; 1996 Aug; 261(2):267-78. PubMed ID: 8757293
[TBL] [Abstract][Full Text] [Related]
4. Computational prediction of the binding site of proteinase 3 to the plasma membrane.
Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N
Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025
[TBL] [Abstract][Full Text] [Related]
5. Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase.
Hajjar E; Korkmaz B; Reuter N
FEBS Lett; 2007 Dec; 581(29):5685-90. PubMed ID: 18023421
[TBL] [Abstract][Full Text] [Related]
6. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
7. 1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.
Laxmikanthan G; Blaber SI; Bernett MJ; Scarisbrick IA; Juliano MA; Blaber M
Proteins; 2005 Mar; 58(4):802-14. PubMed ID: 15651049
[TBL] [Abstract][Full Text] [Related]
8. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
9. Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis.
Korkmaz B; Hajjar E; Kalupov T; Reuter N; Brillard-Bourdet M; Moreau T; Juliano L; Gauthier F
J Biol Chem; 2007 Jan; 282(3):1989-97. PubMed ID: 17088257
[TBL] [Abstract][Full Text] [Related]
10. Binding pockets on the surface of human leukocyte elastase and human leukocyte cathepsin G. Implications to the design of inhibitors derived from human C-reactive protein.
Yavin EJ; Eisenstein M; Fridkin M
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):71-8. PubMed ID: 9575343
[TBL] [Abstract][Full Text] [Related]
11. Proteinase 3 hydrolysis of peptides derived from human elastin exon 24.
Lombard C; Bouchu D; Wallach J; Saulnier J
Amino Acids; 2005 Jun; 28(4):403-8. PubMed ID: 15895295
[TBL] [Abstract][Full Text] [Related]
12. The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity.
Kiss AL; Hornung B; Rádi K; Gengeliczki Z; Sztáray B; Juhász T; Szeltner Z; Harmat V; Polgár L
J Mol Biol; 2007 Apr; 368(2):509-20. PubMed ID: 17350041
[TBL] [Abstract][Full Text] [Related]
13. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
[TBL] [Abstract][Full Text] [Related]
14. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
Fang B; Fu G; Agniswamy J; Harrison RW; Weber IT
Apoptosis; 2009 May; 14(5):741-52. PubMed ID: 19283487
[TBL] [Abstract][Full Text] [Related]
15. Subsite specificity (S3, S2, S1', S2' and S3') of oligopeptidase B from Trypanosoma cruzi and Trypanosoma brucei using fluorescent quenched peptides: comparative study and identification of specific carboxypeptidase activity.
Hemerly JP; Oliveira V; Del Nery E; Morty RE; Andrews NW; Juliano MA; Juliano L
Biochem J; 2003 Aug; 373(Pt 3):933-9. PubMed ID: 12737623
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
17. The N-terminal tetrapeptide of neutrophil proteinase 3 causes S-phase arrest in granulopoietic progenitors.
Sköld S; Rosberg B; Olofsson T
Exp Hematol; 2005 Nov; 33(11):1329-36. PubMed ID: 16263417
[TBL] [Abstract][Full Text] [Related]
18. Carboxy-monopeptidase substrate specificity of human cathepsin X.
Devanathan G; Turnbull JL; Ziomek E; Purisima EO; Ménard R; Sulea T
Biochem Biophys Res Commun; 2005 Apr; 329(2):445-52. PubMed ID: 15737607
[TBL] [Abstract][Full Text] [Related]
19. A multistep approach to structure-based drug design: studying ligand binding at the human neutrophil elastase.
Steinbrecher T; Case DA; Labahn A
J Med Chem; 2006 Mar; 49(6):1837-44. PubMed ID: 16539369
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
